Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-30Diet-Based Treatment for Migraine Relief
-
CLINICAL_TRIALS study record update · 2026-10-30Treatment for Migraine and Mood (TEAM-M): A Randomized Controlled Trial of a Mindfulness-based Training Program
-
CLINICAL_TRIALS study record update · 2026-10-30Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations
-
CLINICAL_TRIALS study record update · 2026-10-29RETROSPECTIVE COHORT STUDY OF PREGNANCY OUTCOMES IN WOMEN EXPOSED TO RIMEGEPANT DURING PREGNANCY
-
CLINICAL_TRIALS study record update · 2026-10-29Effect of a Home-based Versus Supervised Exercise Program in Patients With Migraine: a Randomized Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-29A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR)
-
CLINICAL_TRIALS study record update · 2026-10-29Cocoa Flavanols for Migraine: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-10-29CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom
-
CLINICAL_TRIALS study results posted · 2026-10-28A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])
-
CLINICAL_TRIALS study record update · 2026-10-28Studio TIARA: Alessitimia ed Emicrania Cronica
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])
-
CLINICAL_TRIALS study record update · 2026-10-28Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine - A Prospective, Randomized, Open Label, Delayed-Start Study to Evaluate the Safety and Performance of the Walther System
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine
-
CLINICAL_TRIALS study record update · 2026-10-27Examining the Effectiveness of Basic Body Awareness Therapy in Individuals With Migraine
-
CLINICAL_TRIALS study record update · 2026-10-27A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department
-
CLINICAL_TRIALS study record update · 2026-10-27The Impact of Spectrally Optimized Ambient White Light on Visual Discomfort, Headache Intensity, and Cognitive Performance Among Those With Migraine: A Randomized Crossover Study
-
CLINICAL_TRIALS study record update · 2026-10-26Family Study of Affective and Anxiety Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2026-10-26A Multicenter, Double-blind, Double-dummy, Randomized, Single-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2026-10-23Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief
-
CLINICAL_TRIALS study record update · 2026-10-23AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE
-
CLINICAL_TRIALS study record update · 2026-10-21A Pragmatic Observational Study to Investigate Machine Prescription as Compared to Treatment-as-usual in Adults Aged 18 Years or Older With Migraine
-
CLINICAL_TRIALS study record update · 2026-10-20Disrupted Spatial and Temporal Nociceptive Filtering in Adolescents With and Risk for Overlapping Pain Conditions
-
CLINICAL_TRIALS study record update · 2026-10-19Migraine Medication Effects on Urinary Symptoms
-
CLINICAL_TRIALS study record update · 2026-10-19A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study